SEC Form D · filed January 3, 2022
Clade Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Jim A. Glasheen · Cambridge, MAExec · DirectorNeil A. White · Cambridge, MADirectorDaniel A. Vasella · Cambridge, MADirectorLeandro A. Vetcher · Cambridge, MAExecMartin A. Murphy · Cambridge, MADirectorChad A. Cowan · Cambridge, MAExec · DirectorYu Hu · Dedham, MADirectorJeffrey R. Theobald · Boston, MADirectorReed J. Oppenheimer · Tulsa, OKExecSamantha Dale Strasser · Dedham, MAExec · DirectorOmri Amirav-Drory · Dedham, MAExec · DirectorOppenheimer Jules Development Properties, LLC · Tulsa, OKDirectorBrian N. Clark · Tallahassee, FLExecPaul N. Woodward · Tallahassee, FLDirectorEric J. Wilkins · Charlotte, NCExec · DirectorStuart M. Christhilf Iv · Charlotte, NCDirectorMark Shaw · Menlo Park, CAExec · DirectorPhilip Summe · Menlo Park, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗